ArticleMedicine2026
Red blood cell folate and depression risk in U.S. women: A dose-response analysis from a nationwide cross-sectional study (2009-2018).
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
In contemporary society, the prevalence of depression among women is worsening and rising annually, influenced by numerous intricate factors. Folate, a B vitamin, is vital for overall human health. This study aimed to investigate the association between red blood cell (RBC) folate levels and depression within a nationally representative group of women in the U.S. We conducted a cross-sectional study to examine the association between depression and RBC folate levels among women in the U.S., using data from the National Health and Nutrition Examination Survey from 2009 to 2018. Participants were stratified by depressive status and categorized into 4 quartiles (Q1-Q4) based on their RBC folate levels. We built both univariate and multivariate regression models to conduct a comprehensive threshold effect analysis on the correlation between RBC folate levels and depression. We analyzed data from 9409 women in the U.S. In the fully adjusted model, when RBC folate was sorted into 4 quartiles, both the lowest (Q1: odds ratio [OR] = 1.396, 95% confidence interval [CI]: 1.135-1.717, P = .0027) and highest (Q4: OR = 1.425, 95% CI: 1.160-1.749, P = .0014) quartiles showed significantly higher odds of depression compared to the reference Q2. Threshold effect analysis identified a breakpoint at 985 nmol/L, indicating a U-shaped association between RBC folate level and depression. Below 985 nmol/L, the risk of depression significantly decreased by 6% per 100 nmol/L increase in RBC folate (OR = 0.9994, 95% CI: 0.9989-0.9999, P = .0099). Above this inflection point, the risk significantly increased by 3% per 100 nmol/L increase (OR = 1.0003, 95% CI: 1.0002-1.0005, P < .0001). A U-shaped association was observed between RBC folate and depression among women in the U.S. Maintaining appropriate RBC folate levels may help reduce depression in women. However, the mechanisms behind both RBC folate and depression still require further in-depth research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.